Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$11 Mln
P/E Ratio
--
P/B Ratio
0.83
Industry P/E
--
Debt to Equity
0.47
ROE
-0.9 %
ROCE
-58.91 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-174.09 Mln
EBITDA
$-200.61 Mln
Net Profit
$-199.83 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Ekso Bionics Holdings (EKSO)
| -30.51 | -26.15 | -25.20 | -69.94 | -45.72 | -32.85 | -43.82 |
|
BSE Sensex*
| -5.65 | -3.07 | -9.18 | 0.22 | 9.95 | 17.63 | 9.82 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Ekso Bionics Holdings (EKSO)
| -75.32 | 110.08 | -55.09 | -56.77 | 4.52 | -68.47 | -41.61 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 16.30 | 11,098.72 | 15.67 | 12.69 | |
| 71.04 | 9,806.74 | 95.07 | 2.52 | |
| 168.21 | 9,045.60 | -- | -25.23 | |
| 272.62 | 10,288.75 | 763.23 | 1.2 |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The... EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California. Read more
CEO & Director
Mr. Scott G. Davis
CEO & Director
Mr. Scott G. Davis
Headquarters
San Rafael, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Ekso Bionics Holdings Inc (EKSO) stood at $ 27 Mln as on 31-Dec-24
The share price of Ekso Bionics Holdings Inc (EKSO) is $0.42 (NASDAQ) as of 14-Mar-2025 16:00 EDT. Ekso Bionics Holdings Inc (EKSO) has given a return of -45.72% in the last 3 years.
Ekso Bionics Holdings Inc (EKSO) has a market capitalisation of $ 11 Mln as on 14-Mar-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Ekso Bionics Holdings Inc (EKSO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Ekso Bionics Holdings Inc (EKSO) and enter the required number of quantities and click on buy to purchase the shares of Ekso Bionics Holdings Inc (EKSO).
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
The CEO & director of Mr. Scott G. Davis. is Ekso Bionics Holdings Inc (EKSO), and CFO & Sr. VP is Mr. Scott G. Davis.
There is no promoter pledging in Ekso Bionics Holdings Inc (EKSO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,103
|
|
|
1,084
|
|
|
1,055
|
|
|
990
|
| Ekso Bionics Holdings Inc. (EKSO) | Ratios |
|---|---|
|
Return on equity(%)
|
-89.52
|
|
Operating margin(%)
|
-61.71
|
|
Net Margin(%)
|
-63.21
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Ekso Bionics Holdings Inc (EKSO) was $0 Mln.
$-0.04
(
